Published in Blood Weekly, April 22nd, 2010
"This device is as useful as blood thinners for the reduction of blood clots after hip replacement and it's superior in safety," said Douglas E. Padgett, M.D., chief of Adult Reconstruction and Joint Replacement at Hospital for Special Surgery, one of the investigators and final author. "This has the potential to change the paradigm as to how we prevent blood clots after hip replacement. The efficacy is the same, the safety is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-04-22)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.